Dissertation > Excellent graduate degree dissertation topics show
Phage random peptide library screening serum tumor markers in nasopharyngeal experimental study
Author: LiuXinQiang
Tutor: HeHaiPing
School: Guangxi Medical University
Course: Oncology
Keywords: Phage peptide library Nasopharyngeal Tumor markers
CLC: R739.63
Type: Master's thesis
Year: 2011
Downloads: 26
Quote: 0
Read: Download Dissertation
Abstract
|
Background and Purpose NPC (Nasopharyngeal Carcinoma, NPC) is a polygenic disease (polygenetic diseases). Currently the diagnosis of nasopharyngeal carcinoma mainly by tissue biopsy, because early symptoms, the patient's five year survival rate is about 50%. However, cancer patients has been shown in vivo to produce the corresponding tumor markers, we can detect these tumor markers for the early diagnosis of NPC. By molecular biology and immunology methods to find those sensitivity, specificity, relatively high tumor marker for early diagnosis of NPC patients to provide new ideas. Phage display technology (phage display technique, PDT) is looking for a specific binding with the target protein polypeptides or proteins relations potent biological tool, its biggest advantage is that can be presented directly to the phenotype and the genotype linked demonstrated out of the foreign protein can be maintained relatively independent spatial structure and biological activity, and use its affinity for the ligand specificity protein or polypeptide of interest screened out, and then sequenced to obtain the corresponding structural and functional information. We used phage display peptide library screening nasopharyngeal carcinoma patients, Amoy selected patients with nasopharyngeal carcinoma tumor antigen-specific expression of the hope for the diagnosis and prognosis of patients with nasopharyngeal carcinoma provide new markers. Method 1. Were used normal human serum and serum of patients with nasopharyngeal carcinoma coated microtiter plate, through the reduction of the screening method, the pre-adsorbed phage with normal serum, and then unbound phage serum of patients with NPC again adsorption, then get nasopharyngeal carcinoma patients with a combination of phage amplification. Repeat screening times. (2) pick a single plaque with screening detected by ELISA in serum of patients with nasopharyngeal carcinoma serum binding situation, choose significantly different phages, and then expand the content of serum samples for testing, and ultimately get to work with patients with nasopharyngeal carcinoma a single serum specific binding phage clones. 3 Extraction and purification of single phage clone DNA, using primers -96 Ⅲ DNA sequencing, according to the peptide and amino acid insertion point into the genetic code table to obtain a short peptide sequence. Results 1 After three screening, pick a single phage obtained after repeatedly identified two specific phage clones better; 2. Were sequenced arrangement for these two short peptide sequences; 3. These two phage clones were identified IgA-ELISA VCA-positive nasopharyngeal carcinoma serum and serum IgA-VCA-negative nasopharyngeal no significant difference; 4 which two phage clones were detected by ELISA in serum nasopharyngeal carcinoma, liver cancer sera sera showed that ovarian cancer patients with nasopharyngeal carcinoma has a specific binding. Conclusions In this study, phage random peptide library screening with nasopharyngeal carcinoma-associated antigen-specific binding peptides for the early diagnosis of nasopharyngeal carcinoma, joint detection and immunotherapy of candidate markers.
|
Related Dissertations
- The Study of Clinical Prognostic Factors in Nasopharyngeal Carcinoma after Intensity Modulated Radiation Therapy,R739.63
- Research for the Expressive Correlation of EBERs and BMI-1 in Nasopharyngeal Carcinoma,R739.63
- Combined Detection of Tumor Markers in the Diagnosis and Treatment of Lung Cancer to Determine the Clinical Significance,R734.2
- Variation of Immune System and Clinical Experiment Indicators in Patients with Gastric Cance and Its Association with 15 STR Loci,R735.2
- The Extraction and Application of Endogenous Serum Phosphopeptides from Lung Cancer Patients,R734.2
- The Expression of Hexokinase Ⅱ in Nasopharyngeal Carcinoma,R739.63
- The E-cadherin Promoter-160 C/A Polymorphism and Nasopharyngeal Carcinoma in a Chinese Population,R739.63
- The Research of Calcium, Phosphorus Concentrations in Saliva of Patients with Nasopharyngeal Carcinoma before and after Radiation Therapy,R739.63
- Related Risk Factors to Caries after Nasopharyngeal Carcinoma Radiotherapy,R739.63
- To Study the Relationship Between Expression of Annexin A5 in Nasopharyngeal Carcinoma,R739.6
- Study of the Expression and Significance of Twist in Nasopharyngeal Carcinoma,R739.63
- Antitumor Effect of Bleomycin-conjugated Single Domain Antibody Against Human Nasopharyngeal Carcinoma,R739.6
- Compared Study on the Different Expression of PGC, PTEN, HER-2, CEA and CA72-4 between Mycotic Gastric Ulcer and Ulcerated Gastric Adenocarcinoma,R735.2
- MicroRNA expression in NPC,R739.63
- Quality Assurance for Hyperthermia in Cervical Lymph Node Metastasis of Nasopharyngeal Carcinoma,R739.63
- 临床研究 Neo-adjuvant Docetaxel and Cisplatin Followed by Concurrent Docetaxel and Cisplatin with Intensity-modulated Radiation Therapy in Treatment of Locally Advanced Recurrent Nasopharynx Cancer,R739.63
- Animal and Clinical Studies of 18F-FDG PET-CT in Early Assessment of Radiotherapy Efficacy of Nasopharyngeal Carcinoma and the Correlation Analysis of Ki67 Expression,R739.63
- Proteomics Analysis of Plasma Membrane of Nasopharyngeal Carcinoma Cell Line,R739.63
- The Preliminary Study of Functional C-1888T Single Nucleotide Polymorphism (SNP) Site in Promoter Region of hPLUNC Gene in Nasopharyngeal Carcinoma,R739.63
- Effects of Qi-Boosting Toxin-Resolving Formula on the Structure of Cellular Adhesion System in the Implanted Tumors with Human NPC Cells Among Nude Mice,R739.63
- The Intervening Effect of Qi-Boosting Toxin-Resolving Formula on the Structures of Cystoskeleton and the Expressive Activities of Associated Protein in Nasopharyngeal Carcinoma Cells,R739.63
CLC: > Medicine, health > Oncology > Department of Otolaryngology tumor > Pharyngeal tumors
© 2012 www.DissertationTopic.Net Mobile
|